½ÃÀ庸°í¼­
»óǰÄÚµå
1488262

÷´Ü â»ó ÇǺ¹Àç ½ÃÀå - ¼¼°è ¹× Áö¿ª ºÐ¼® : Á¦Ç°º°, Áö¿ªº°, ±¹°¡º° ºÐ¼®, °æÀï »óȲ ¹× ¿¹Ãø(2023-2030³â)

Advanced Wound Dressing Market - A Global and Regional Analysis: Focus on Product, Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BIS Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°è ÷´Ü â»ó ÇǺ¹Àç ½ÃÀå ±Ô¸ð´Â 2022³â 62¾ï 160¸¸ ´Þ·¯¿¡¼­ 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 3.89% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 83¾ï 8,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°í·É Àα¸ Áõ°¡, ¸¸¼º »óó À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, »óó Ä¡·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ â»ó ÇǺ¹Àç ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Çõ½ÅÀû ¼ÒÀç¿Í ±â¼ú·Î ±¸¼ºµÈ ÷´Ü â»ó ÇǺ¹Àç´Â ±âÁ¸ â»ó ÇǺ¹Àç¿¡ ºñÇØ »óó Ä¡À¯¸¦ ÃËÁøÇÏ°í °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϸç ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ »ê¾÷Àº Ä¡¿­ÇÑ °æÀïÀÌ Æ¯Â¡À̸ç, ÁÖ¿ä ±â¾÷µéÀº ½ÃÀå ÀÔÁö¸¦ °­È­Çϰí Àü ¼¼°è ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿Í È¯ÀÚÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ »ç¾÷ È®Àå, Á¦ÈÞ ¹× ÇÕº´°ú °°Àº Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2030³â
2023³â Æò°¡ 64¾ï 1,850¸¸ ´Þ·¯
2030³â Àü¸Á 83¾ï 8,310¸¸ ´Þ·¯
CAGR 3.89%

÷´Ü â»ó ÇǺ¹Àç ½ÃÀåÀº Àüü »óó Ä¡·á »ê¾÷¿¡¼­ °¡Àå ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ¹ßÀüÇϰí ÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù. ÷´Ü â»ó ÇǺ¹Àç¿¡´Â ´ç´¢º´¼º ±Ë¾ç, ¿åâ, ¼ö¼ú »óó, È­»ó µî ±Þ¼º ¹× ¸¸¼º »óóÀÇ Ä¡À¯ °úÁ¤À» ÃËÁøÇϵµ·Ï ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌµé µå·¹½ÌÀº ÇÏÀ̵å·ÎÄÝ·ÎÀ̵å, ÇÏÀ̵å·Î°Ö, Æû ¼ÒÀç, ¾Ë±ä»ê, Ç×±ÕÁ¦ µî Çõ½ÅÀûÀÎ ¼ÒÀ縦 ÅëÇÕÇÏ¿© ±âÁ¸ µå·¹½Ì¿¡ ºñÇØ ¿ì¼öÇÑ ¼öºÐ °ü¸®, »ïÃâ¹° Èí¼ö ¹× Ç×±Õ Æ¯¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. Àü ¼¼°è Àα¸ °í·ÉÈ­, ¸¸¼ºÁúȯ Áõ°¡, È¿À²ÀûÀÎ »óó °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÷´Ü â»ó ÇǺ¹Àç ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, ¿Ü·¡ ȯÀÚ »óó Ä¡·á·ÎÀÇ Àüȯ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ¼±µÎ ¾÷üµé °£ÀÇ Àü·«Àû Á¦ÈÞ, ÇÕº´ ¹× ÀμöÇÕº´Àº ¾÷°èÀÇ °æÀï »óȲÀ» ³ªÅ¸³»¸ç Á¦Ç° °³¹ß ¹× À¯Åë ä³ÎÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¦Ç°º°·Î´Â ¾Ë±ä»ê µå·¹½ÌÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

¾Ë±ä»ê µå·¹½Ì°ú Äݶó°Õ µå·¹½ÌÀº µ¶Æ¯ÇÑ Ä¡·á Ư¼º°ú ´Ù¾çÇÑ ¿ëµµ·Î ÀÎÇØ ÷´Ü â»ó ÇǺ¹Àç ½ÃÀåÀÇ Áö¹èÀû ¼¼·ÂÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÇØÁ¶·ù¿¡¼­ ÃßÃâÇÑ ¾Ë±ä»ê µå·¹½ÌÀº »óó »ïÃâ¹°°ú Á¢ÃËÇÏ¿© °ÖÀ» Çü¼ºÇÏ°í »óó Ä¡À¯¿¡ ÀûÇÕÇÑ ½ÀÀ± »óó ȯ°æÀ» Á¶¼ºÇϱ⠶§¹®¿¡ Áߵ¿¡¼­ ÁßÁõÀÇ »ïÃ⼺ »óó °ü¸®¿¡ Ź¿ùÇÕ´Ï´Ù. ¹Ý¸é, µ¿¹° À¯·¡ ¶Ç´Â ÇÕ¼º Äݶó°Õ µå·¹½ÌÀº ¼¼Æ÷ Áõ½ÄÀ» À§ÇÑ ¹ßÆÇÀ» Á¦°øÇϰí Á¶Á÷ Àç»ýÀ» ÃËÁøÇÏ¿© »óó Ä¡À¯¸¦ ÃËÁøÇϸç, ƯÈ÷ ¸¸¼º »óó ¹× ºñÄ¡À¯¼º »óó¿¡ È¿°úÀûÀÔ´Ï´Ù.

÷´Ü â»ó ÇǺ¹Àç ½ÃÀåÀº ´Ù¾çÇÑ Á¦Ç° À¯ÇüÀ¸·Î ºÐ·ùµÇ¸ç, °¢ À¯ÇüÀº 2023³âºÎÅÍ 2030³â±îÁö À¯¸ÁÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Ç¸®ÄÜ Æû µå·¹½ÌÀº Æí¾ÈÇÔ°ú ½Àµµ °ü¸® Ư¼ºÀ¸·Î ÀÎÇØ CAGR 4.60%·Î ½ÃÀåÀ» ¼±µµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àº°è Ç×±Õ µå·¹½ÌÀº °¨¿° ¿¹¹æ¿¡ ´ëÇÑ Æò°¡·Î CAGR 3.11%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½ÌÀº CAGR 3.37%·Î ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ½Ç¸®ÄÜ Æû µå·¹½Ì°ú Çʸ§ µå·¹½ÌÀº ´Ù¿ëµµ·Î ÀÎÇØ CAGR 4.07%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Äݶó°Õ µå·¹½Ì°ú ¾Ë±ä»ê µå·¹½ÌÀº ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖÀ¸¸ç, °íÈí¼ö¼º µå·¹½Ì Àç·á¿Í ÇÏÀ̵å·Î°Ö µå·¹½Ì Àç·á´Â Èí¼ö¼º°ú ¼öºÐ °ø±Þ ±â´ÉÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù.

ÁøÃâ ±â¾÷:

  • 3M
  • Advancis Medical
  • Cardinal Health
  • Coloplast
  • ConvaTec
  • Huizhou Foryou Medical Devices CO.
  • McKesson Medical Surgical Inc.
  • Medline Industries
  • Molnlycke
  • Smith & Nephew

¼¼°è ÷´Ü â»ó ÇǺ¹Àç ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, Á¦Ç°º°¡¤Áö¿ªº°¡¤ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ½ÃÀå

Á¦2Àå Á¦Ç°

  • Á¦Ç° ºÐ·ù
  • Á¦Ç° °³¿ä
  • ¼¼°èÀÇ Ã·´Ü â»ó ÇǺ¹Àç ½ÃÀå : Á¦Ç° À¯Çüº°
    • ¾Ë±ä»ê¿° µå·¹½Ì
    • Äݶó°Õ µå·¹½Ì
    • Á¢ÃËÃþ µå·¹½Ì
    • Çʸ§ µå·¹½Ì
    • ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì
    • ÇÏÀ̵å·Î°Ö µå·¹½Ì
    • ºñ½Ç¸®ÄÜ Æû µå·¹½Ì
    • ºñÀº Ç×±Õ µå·¹½Ì
    • ½Ç¸®ÄÜ Æû µå·¹½Ì
    • Àº Ç×±Õ µå·¹½Ì
    • ÃÊÈí¼ö¼º µå·¹½Ì

Á¦3Àå Áö¿ª

  • Áö¿ªº° °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ÄÝ·Òºñ¾Æ
    • ¸ß½ÃÄÚ
  • À¯·´
    • ÇÁ¶û½º
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • Æ÷¸£Åõ°¥
    • ³×´ú¶õµå
    • ¾ÆÀÏ·£µå
    • º§±â¿¡
    • ½ºÀ§½º
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
    • Çɶõµå
    • µ¶ÀÏ
    • üÄÚ
    • ·¯½Ã¾Æ
    • Æú¶õµå
    • ¿À½ºÆ®¸®¾Æ
    • ·ç¸¶´Ï¾Æ
    • ½½·Î¹ÙŰ¾Æ
    • ±×¸®½º
    • ÅÍŰ
    • ¿ìÅ©¶óÀ̳ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • È£ÁÖ
    • ÀϺ»
    • ¸»·¹À̽þÆ
    • Áß±¹
    • Àεµ
    • ű¹
    • Çѱ¹
  • ±âŸ Áö¿ª

Á¦4Àå ½ÃÀå : °æÀï º¥Ä¡¸¶Å·

  • ÁÖ¿ä Àü·«¡¤Àü°³

Á¦5Àå Á¶»ç ¹æ¹ý

ksm 24.06.10

Introduction of Advanced Wound Dressing

The global advanced wound dressing market, valued at $6,201.6 million in 2022 and projected to reach $8,383.1 million by 2030, exhibiting a compound annual growth rate (CAGR) of 3.89% during the forecast period from 2023 to 2030, is witnessing significant growth driven by the increasing prevalence of chronic wounds, rising geriatric population, and advancements in wound care technologies. Advanced wound dressings, comprising a range of innovative materials and technologies, are designed to accelerate wound healing, minimize infection risks, and improve patient outcomes compared to traditional wound dressings. This market segment is characterized by intense competition, with key players engaging in strategic initiatives such as expansions, partnerships, and mergers to strengthen their market presence and cater to the evolving needs of healthcare providers and patients globally.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2030
2023 Evaluation$6,418.5 Million
2030 Forecast$8,383.1 Million
CAGR3.89%

The market for advanced wound dressings represents a dynamic and rapidly evolving segment within the broader wound care industry. Advanced wound dressings encompass a diverse array of products designed to enhance the healing process of acute and chronic wounds, including diabetic ulcers, pressure ulcers, surgical wounds, and burns. These dressings incorporate innovative materials such as hydrocolloids, hydrogels, foams, alginates, and antimicrobial agents, providing superior moisture management, exudate absorption, and antimicrobial properties compared to traditional dressings. With an aging global population, increasing incidence of chronic diseases, and growing demand for efficient wound management solutions, the advanced wound dressings market is experiencing robust growth. Key factors driving market expansion include technological advancements, rising healthcare expenditures, and a shift towards outpatient wound care settings. Additionally, strategic collaborations, mergers, and acquisitions among leading market players underscore the competitive landscape and drive innovation in product development and distribution channels.

Industrial Impact

The advanced wound dressings market is currently witnessing a surge in strategic activities, with companies such as Argentum Medical, LLC and Sanara MedTech Inc. at the forefront of business expansion, partnerships, and collaborations. Human BioSciences Inc.'s entry into Middle Eastern and Indian markets underscores the increasing international demand for advanced wound care products. Contractual agreements, such as those of Argentum Medical, LLC with various U.S. departments, highlight the significance of governmental and defense sectors as major end-users in the market. This surge of strategic initiatives signals a highly competitive environment, with key players aiming to innovate, expand globally, and strengthen their market presence through collaborative and growth-oriented strategies.

Market Segmentation:

Segmentation: by Product

  • Alginate Dressings
  • Collagen Dressings
  • Contact Layer Dressings
  • Film Dressings
  • Hydrocolloid Dressings
  • Hydrogel Dressings
  • Non-Silicone Foam Dressings
  • Non-silver Antimicrobial Dressings
  • Silicone Foam Dressings
  • Silver Antimicrobial Dressings
  • Superabsorbant Dressings

Alginate Dressings Segment to Dominate the Advanced Wound Dressing Market (by Product)

Alginate wound dressings and collagen wound dressings emerge as dominant forces within the advanced wound care dressings market due to their unique therapeutic properties and versatile applications. Alginate dressings, derived from seaweed, excel in managing moderate to heavily exuding wounds by forming a gel upon contact with wound exudate, promoting a moist wound environment conducive to healing. On the other hand, collagen dressings, derived from animal sources or synthesized, facilitate wound healing by providing a scaffold for cellular ingrowth and promoting tissue regeneration, making them particularly effective for chronic and non-healing wounds. Their widespread adoption and proven efficacy make alginate and collagen dressings indispensable components of advanced wound care protocols, driving their prominence in the product segment.

Segmentation: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Russian Federation
    • Turkey
    • Poland
    • Belgium
    • Sweden
    • Ireland
    • Norway
    • Austria
    • Denmark
    • Finland
    • Portugal
    • Czech Republic
    • Romania
    • Greece
    • Slovakia
    • Ukraine
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Malaysia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Colombia
    • Argentina
    • Chile
  • Rest-of-the-World

The advanced wound dressings market is segmented into various product types, each exhibiting promising growth from 2023 to 2030. Silicone foam dressings lead with a CAGR of 4.60%, driven by their comfort and moisture management properties. Silver antimicrobial dressings, valued for infection control, grow at 3.11% CAGR. Hydrocolloid dressings show steady growth at 3.37% CAGR. Non-silicone foam and film dressings grow over 4.07% CAGR due to versatility. Collagen and alginate dressings expand steadily, while superabsorbent and hydrogel dressings gain popularity for absorbency and hydration capabilities. This diverse product range meets varied wound care needs, reflecting the market's dynamic nature.

Recent Developments in the Advanced Wound Dressings Market

  • In July 2023, Human BioSciences entered into a contract in Qatar that highlights the company's commitment to providing high-quality wound care solutions to healthcare providers in the Middle East and GCC, addressing the growing demand for advanced medical products in the area.
  • In March 2023, Medtrade partnered with Pennine Healthcare, a UK-based manufacturer. This collaboration aims to produce innovative range of wound care products.
  • In January 2023, Convatec Inc. announced the US launch of ConvaFoam. This innovative family of advanced foam dressings is thoughtfully designed to meet the diverse needs of both healthcare providers and their patients. ConvaFoam emerges as the go-to dressing for simplified wound management and effective skin protection.
  • In November 2023, Sanara MedTech Inc. and InfuSystem Holdings, Inc. have joined forces to establish a new partnership named SI Wound Care, LLC. Through this partnership, InfuSystem will be able to introduce cutting-edge products, including NPWT devices and supplies from Cork Medical, LLC, as well as Sanara's advanced wound care product line and related services, to a wider audience of potential customers.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: Analysis of product trends and innovations in the market allows organizations to identify opportunities for enhancing their existing product portfolio or developing new products to meet evolving customer needs.

Growth/Marketing Strategy: Regional data can inform organizations about market growth rates, demand hotspots, and emerging opportunities, enabling them to allocate resources strategically and prioritize market expansion efforts.

Competitive Strategy: Competitor data, including product offerings, market positioning, and regional presence, provides organizations with insights into competitor strengths, weaknesses, and strategies, facilitating benchmarking and competitive analysis.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of advanced wound dressings.
  • The market contribution of advanced wound dressing is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
  • The market has been mapped based on the available advanced wound dressings solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in advanced wound dressings, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, , directories, and major databases, among others.
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • Segmentation and percentage shares
  • Data for market value
  • Key industry trends of the top players of the market
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

In the global advanced wound dressing market, the competition within the market is driven by several factors including innovation, and product quality,. Many companies focus on technological advancements to enhance the efficacy of advanced wound dressings, aiming to improve patient outcomes and reduce overall healthcare costs.

Some prominent names established in this market are:

  • 3M
  • Advancis Medical
  • Cardinal Health
  • Coloplast
  • ConvaTec
  • Huizhou Foryou Medical Devices CO., Ltd.
  • McKesson Medical Surgical Inc.
  • Medline Industries
  • Molnlycke
  • Smith & Nephew

Table of Contents

Executive Summary

1 Market

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion Criteria
    • 1.2.1 Inclusion
    • 1.2.2 Exclusion Criteria
  • 1.3 Key Questions Answered
  • 1.4 Analysis and Forecast Note
  • 1.5 Key Findings

2 Product

  • 2.1 Product Segmentation
  • 2.2 Product Summary
  • 2.3 Global Advanced Wound Dressing Market (by Product Type)
    • 2.3.1 Alginate Dressings
    • 2.3.2 Collagen Dressings
    • 2.3.3 Contact Layer Dressings
    • 2.3.4 Film Dressings
    • 2.3.5 Hydrocolloid Dressings
    • 2.3.6 Hydrogel Dressings
    • 2.3.7 Non-Silicone Foam Dressings
    • 2.3.8 Non-Silver Antimicrobial Dressings
    • 2.3.9 Silicone Foam Dressings
    • 2.3.10 Silver Antimicrobial Dressings
    • 2.3.11 Superabsorbent Dressings

3 Region

  • 3.1 Regional Summary
  • 3.2 North America
    • 3.2.1 U.S.
    • 3.2.2 Canada
  • 3.3 Latin America
    • 3.3.1 Argentina
    • 3.3.2 Brazil
    • 3.3.3 Chile
    • 3.3.4 Colombia
    • 3.3.5 Mexico
  • 3.4 Europe
    • 3.4.1 France
    • 3.4.2 U.K.
    • 3.4.3 Spain
    • 3.4.4 Italy
    • 3.4.5 Portugal
    • 3.4.6 Netherlands
    • 3.4.7 Ireland
    • 3.4.8 Belgium
    • 3.4.9 Switzerland
    • 3.4.10 Norway
    • 3.4.11 Denmark
    • 3.4.12 Sweden
    • 3.4.13 Finland
    • 3.4.14 Germany
    • 3.4.15 Czech Republic
    • 3.4.16 Russia
    • 3.4.17 Poland
    • 3.4.18 Austria
    • 3.4.19 Romania
    • 3.4.20 Slovakia
    • 3.4.21 Greece
    • 3.4.22 Turkey
    • 3.4.23 Ukraine
  • 3.5 Asia-Pacific
    • 3.5.1 Australia
    • 3.5.2 Japan
    • 3.5.3 Malaysia
    • 3.5.4 China
    • 3.5.5 India
    • 3.5.6 Thailand
    • 3.5.7 South Korea
  • 3.6 Rest-of-the-World

4 Market: Competitive Benchmarking

  • 4.1 Key Strategies and Developments

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Data Triangulation
  • 5.2 Market Estimation and Forecast
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦